Dalteparin anticoagulation in paediatric home haemodialysis
- Resource Type
- Authors
- Pallavi Yadav; Miranda Lutkin; Lynsey Stronach; Daljit Hothi
- Source
- Pediatric Nephrology. 33:2337-2341
- Subject
- Dalteparin
Male
Nephrology
medicine.medical_specialty
Adolescent
medicine.drug_class
medicine.medical_treatment
030232 urology & nephrology
Hemodialysis, Home
Hemorrhage
030204 cardiovascular system & hematology
03 medical and health sciences
0302 clinical medicine
Internal medicine
Humans
Medicine
Dosing
Child
Adverse effect
Blood Coagulation
Dialysis
Retrospective Studies
Dose-Response Relationship, Drug
Dalteparin sodium
business.industry
Anticoagulant
Age Factors
Anticoagulants
Thrombosis
Heparin
Clot formation
United Kingdom
Child, Preschool
Pediatrics, Perinatology and Child Health
Kidney Failure, Chronic
Female
business
Follow-Up Studies
medicine.drug
- Language
- ISSN
- 1432-198X
0931-041X
The aim of this study was to investigate whether dalteparin is a safe and effective anticoagulant for paediatric home haemodialysis (HD) and to assess the determinants of dosing. Data were collected for all children (